Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma

Differential Expression and Potential Value of c-MYC in Non-invasive and Invasive Mammary Carcinoma

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06357338

Enrollment

Registered

2024-04-10

Start date

2024-03-19

Completion date

2026-04-01

Last updated

2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Breast Cancer

Brief summary

Retrospective observational study to evaluate c-MYC expression in non invasive and invasive mammry carcinoma

Detailed description

To correlate different levels of c-MYC expressions with variable clinical and pathological parameters of mammary carcinoma (such as patients' ages, tumor grading, staging, laterality, focality and nodal metastasis, co-existing in-situ components). This study will be carried out on archived formalin-fixed and paraffin embedded tissue blocks that were belonged to 70 women with breast lumps.

Interventions

OTHERno intervention

No intervention

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

15 Years to No maximum

Inclusion criteria

Specimens of Modified Radical Mastectomies from breast carcinoma patients

Exclusion criteria

* Cases with insufficient clinical data. * Tissue blocks of destroyed or insufficient material, unfit for diagnosis. * Cases who received pre-operative chemotherapy.

Design outcomes

Primary

Measure	Time frame	Description
role of c-MYC in breast cancer	1 year	difference between expression of c-MYC in non invasive and invasive mammary carcinoma

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026